RYAOF Ryanair Holdings Plc $RYAOF Company Overview

New Post Public Reply Private Reply Replies (0) Message Board

May 17, 2015 at 5:29 PM

RYAOF Ryanair Holdings Plc $RYAOF Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=RYAOF&am...mp;yt0=Go!

Last Updated: 05/17/2015 16:29:39

Current Price and Quotes
Last Price 12.45
Previous Close 12.45 Open N/A
Daily Range N/A - N/A 52wk Range 9.287 - 12.45
Volume 0 Dividend N/A
Average Vol (30d) 279 Net Dividend Yield N/A

Financials
Period Ending Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Total Revenue 6,941,900 6,258,700 5,846,400 5,150,600
Cost of Revenue 4,504,700 3,978,300 3,611,700 3,155,100
Gross Profit 2,437,200 2,280,400 2,234,700 1,995,500
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,044,600 937,700 913,100 908,700
Non-Recurring Items - - - -
Other 484,900 422,400 411,800 394,100
Operating Income 907,700 920,400 909,800 692,800
Income From Continuing Operations

Add'l Income/Expense Items 22,000 41,000 78,500 37,700
Earnings Before Interest and Tax 929,800 961,400 988,400 730,600
Interest Expense 114,700 127,300 145,400 133,300
Earnings Before Tax 815,100 834,100 843,000 597,300
Income Tax 94,500 104,600 96,700 65,700
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 720,600 729,500 746,300 531,600
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 720,600 729,500 746,300 531,600
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 720,600 729,500 746,300 531,600

Recent News
Source
May 6, 2015 JETS: The Airline Industry ETF Has Nothing New To Offer Seeking Alpha
Apr 28, 2015 Gradual pace to fare cuts from Ryanair Seeking Alpha
Apr 22, 2015 Manchester Car Parking Experts Demand Urgent Investigation over Ryanair Passport Checks ReleaseWire
Apr 8, 2015 Cheap Airport Car Parking Experts Offer Tips on Gaining Cheap Ryanair Flights ReleaseWire
Mar 20, 2015 Ryanair Confuse Passengers over Cheap America Flights Said Ukairportcarparks.co.uk ReleaseWire
Mar 20, 2015 Ryanair says never mind all that transatlantic talk Seeking Alpha
Mar 18, 2015 In2town Press Release Shocked Ryanair Refused a Sick Lad to Board Their Flight ReleaseWire
Mar 18, 2015 Manchester Airport Car Parking Comparison Site Shocked over Ryanair Refusal to Let Sick Child Board Flight ReleaseWire
Mar 17, 2015 UKairportcarparks.co.uk Says Do Not Get Excited over Ryanair Ten Pound American Cheap Flights ReleaseWire
Mar 17, 2015 Ryanair aims to disrupt transatlantic airline market Seeking Alpha

1
2
3
next >

RYAOF Ryanair Holdings Plc Research DD Guide

Stock Message Board http://investorshangout.com/search?q=RYAOF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/RYAOF/quote
Stock Chart http://www.otcmarkets.com/stock/RYAOF/chart
Company Info http://www.otcmarkets.com/stock/RYAOF/company-info
Recent News http://www.otcmarkets.com/stock/RYAOF/news
Financials http://www.otcmarkets.com/stock/RYAOF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/RYAOF/filings
Short Sales http://www.otcmarkets.com/stock/RYAOF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/RYAOF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/RYAOF/research
Summary http://finance.yahoo.com/q?s=RYAOF
Historical Prices http://finance.yahoo.com/q/hp?s=RYAOF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=RYAOF
Basic Chart http://finance.yahoo.com/q/bc?s=RYAOF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=RYAOF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=RYAOF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=RYAOF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=RYAOF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=RYAOF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=RYAOF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=RYAOF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=RYAOF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=RYAOF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=RYAOF
Balance Sheet http://finance.yahoo.com/q/bs?s=RYAOF
Cash Flow http://finance.yahoo.com/q/cf?s=RYAOF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/RYAOF
Market Watch http://www.marketwatch.com/investing/stock/RYAOF
Bloomberg http://www.bloomberg.com/quote/RYAOF:US
Morningstar http://quotes.morningstar.com/stock/s?t=RYAOF
Bussinessweek http://investing.businessweek.com/research/st...cker=RYAOF
Barchart http://www.barchart.com/quotes/stocks/RYAOF
OTC Short Report http://otcshortreport.com/index.php?index=RYAOF
Investopedia http://www.investopedia.com/markets/stocks/RYAOF/?wa=0

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...